International normalized ratio and anticoagulation

Arch Intern Med. 2003 May 26;163(10):1242-3; author reply 1244. doi: 10.1001/archinte.163.10.1242-c.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Dose-Response Relationship, Drug
  • Embolism / mortality
  • Embolism / prevention & control*
  • Endpoint Determination
  • Female
  • Hemorrhage / chemically induced
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • International Normalized Ratio*
  • Male
  • Middle Aged
  • Neoplasms / complications*
  • Neoplasms / drug therapy*
  • Neoplasms / mortality
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Survival Analysis
  • Treatment Outcome
  • Venous Thrombosis / mortality
  • Venous Thrombosis / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Warfarin